Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Eli Lilly opens new diabetes-focused R&D center in China
The focus of LCRDC is on the discovery of new diabetes medicines with novel mechanisms of action to delay the progression of the disease. The new R&D center
The focus of LCRDC is on the discovery of new diabetes medicines with novel mechanisms of action to delay the progression of the disease. The new R&D center
As part of the EAP, enrollment of eligible men with metastatic castration-resistant prostate cancer previously treated with docetaxel chemotherapy has been started. The study, sponsored by Medivation and
The company submitted the application based on results of the PRIMA study (Privigen Impact on Mobility and Autonomy), a single-arm study designed to evaluate the safety and efficacy
The company is conducting the Phase 1/2 trial in collaboration with the Melanoma Research Foundation Breakthrough Consortium (MRFBC). MRFBC member, the Abramson Cancer Center of the University of
The patented proprietary dissolvable non-immunogenic polymer drug delivery system platform has demonstrated efficacy in biofilm and infection eradication, without significant systemic API levels. RBI president and CEO William
The filing is based on a global Phase III clinical development program, including nine multicenter, randomized clinical studies, which evaluated the safety and efficacy of canagliflozin across the
The PK substudy will confirm the low levels of systemic exposure previously observed in preclinical studies of the product. The company will collect the blood samples earlier to
With the investment, the company expects to make sure that the supply of substances from the well-stocked research pipeline is available for clinical studies in adequate amounts. Boehringer
In relation to the establishment, Ariana has appointed James Shanahan as VP of business development. James was previously a co-founder and is current board member of SynDevRx. Ariana
The new biosensor is pre-immobilized with novel nickel-charged tri-nitrilotriacetic (Tri-NTA) groups enabling direct method for quantitation and kinetic analysis of polyhistidine-tagged (HIS-tagged) biomolecules. ForteBio division marketing vice president